Thai investors told of opportunities overseas

MONDAY, SEPTEMBER 21, 2015
Thai investors told of opportunities overseas

TMB Asset Management (TMBAM) said investment opportunities are rife during the current high fluctuation and uncertainties in the world's money markets via global fund that are more selective in term of equities which has high organic revenue growth and pr

“TMBAM wants Thai investors to have a global investor’s view by spreading out part of their investment abroad to increase the chances for more returns and to better manage their risks and going forward we are confidence that the return from equity is still better than other assets and we believe that shares’ with strong fundamental and quality growth are still out there all over the world,” said TMBAM’s director and chief executive officer, Somjin Sornpaisarn. 
The firm’s global equity fund is currently being co-managed by Wellington Management, a US-based investment management company with assets under management of around US$936 billion as of June.
“Wellington used the macroeconomic picture only as part of its decision-making process and they based their equity selection on the quality of the companies as a core and I believe that investment will have to continue even under high fluctuation periods and the idea of not investing at all might not be a good policy at the moment,” he added.
Somjin explained that Wellington based its equity selection on companies with high organic revenue growth on forward-looking bases in the next 5-7 years, companies with high-quality returns in terms of free cash flow margins on forward-looking bases, low valuation based on the free cash flow margin, companies that administrators are committed in providing capital returns to their shareholders and companies with improving fundamentals both in the sector level and the stock level.
The sectors where these companies are currently located globally and what TMBAM and Wellington are investing in via TMB Global Quality Growth fund includes the health care sector where the immune-oncology impact on cancer treatment has provided a promising growth, Internet and technology software and service-driven productivity, low cost and secure Internet distribution, mobile device component manufacturers, investment advisory services and products, favourable environment for generic drug pricing and volumes, he revealed.